The landscape of dementia prognosis has progressed considerably with the appearance of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-based tests that will detect Alzheimer's pathology several years in advance of indications arise. While these technological developments symbolize impressive development in knowledge neur